Ellen Capon - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Ellen Capon's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Ellen Capon
Verified
Development Editor, Kogan Page Publishing
United Kingdom
Beats
Lifestyle , Parenting , Health , Humor , Satire
gossip, gaming, sports
Content
By Ellen Capon| Drug Target Review Verified Posted: 1 November 2024 | Drug Target Review | The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice. Scientists at the UK Dementia Research Institute, University of Cambridge, have identified a drug commonly used to treat glaucoma can protect against tau protein build-up in the brain in genetically engineered zebrafish and mice.
By Ellen Capon| Drug Target Review Verified Posted: 31 October 2024 | Drug Target Review | Researchers have uncovered a how INPP4B, alongside PIKfyve and TRPML-1, drives pancreatic cancer metastasis. Researchers at the University of Toronto, Toronto Metropolitan University and the Princess Margaret Cancer Centre have discovered new insights into the molecular mechanism that drives the aggressiveness of pancreatic cancer.
By Ellen Capon| Drug Target Review Verified Posted: 1 November 2024 | Drug Target Review | The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice. Scientists at the UK Dementia Research Institute, University of Cambridge, have identified a drug commonly used to treat glaucoma can protect against tau protein build-up in the brain in genetically engineered zebrafish and mice.